D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections
Abstract The excessive use of antifungal agents, compounded by the shortage of new drugs being introduced into the market, is causing the accumulation of multi-resistance phenotypes in many fungal strains. Consequently, new alternative molecules to conventional antifungal agents are urgently needed...
Guardado en:
Autores principales: | Pauline Dartevelle, Claire Ehlinger, Abdurraouf Zaet, Christian Boehler, Morgane Rabineau, Benoit Westermann, Jean-Marc Strub, Sarah Cianferani, Youssef Haïkel, Marie-Hélène Metz-Boutigue, Céline Marban |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6542be9b5ef34063b0fd3b1f1dd72f6f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
por: Francesco Scavello, et al.
Publicado: (2021) -
Strongly Adhesive and Antimicrobial Peptide-Loaded, Alginate–Catechol-Based Gels for Application against Periimplantitis
por: Sébastien Baixe, et al.
Publicado: (2021) -
IN VITRO ANTIFUNGAL ACTIVITY OF POTASH ALUM AGAINST CANDIDA ALBICANS ON ACRYLIC RESIN
por: Muhammad Irshad, et al.
Publicado: (2020) -
Mechanisms of the antifungal action of marine metagenome-derived peptide, MMGP1, against Candida albicans.
por: Muthuirulan Pushpanathan, et al.
Publicado: (2013) -
Antifungal Effects and Potential Mechanisms of Benserazide Hydrochloride Alone and in Combination with Fluconazole Against Candida albicans
por: Chen X, et al.
Publicado: (2021)